Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?
Manoj Kumar
Citation Information :
Kumar M. Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?. Indian J Crit Care Med 2016; 20 (4):207-209.
Bouglé A, Harrois A, Duranteau J. Resuscitative strategies in traumatic hemorrhagic shock. Ann Intensive Care 2013;3:1.
Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185.
Kumar M, Rao DN, Mohanty S, Selvi A, Bhoi S. Interleukin (IL)-8 is an early predictor of mortality following trauma hemorrhagic shock. Int J Adv Res Biol Sci 2015;2:12-20.
Livingston DH, Anjaria D, Wu J, Hauser CJ, Chang V, Deitch EA, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003;238:748-53.
Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A. Erythropoiesis in multiply injured patients. J Trauma 2006;61:1285-91.
Schubert T, Echtenacher B, Hofstädter F, Männel DN. TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis. Lab Invest 2003;83:1743-50.
Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995;165:538-46.
Badami CD, Livingston DH, Sifri ZC, Caputo FJ, Bonilla L, Mohr AM, et al. Hematopoietic progenitor cells mobilize to the site of injury after trauma and hemorrhagic shock in rats. J Trauma 2007;63:596-600.
Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, Socolovsky M. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 2006;108:123-33.
Jelkmann I, Jelkmann W. Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother 2013;40:310-8.
Elliott S, Sinclair AM. The effect of erythropoietin on normal and neoplastic cells. Biologics 2012;6:163-89.
Kumar M, Bhoi S. Does erythropoietin reactivate bone marrow dysfunction in trauma hemorrhagic shock? Int J Crit Illn Inj Sci 2015;5:230-1.
Francisco-Cruz A, Aguilar-Santelises M, Ramos-Espinosa O, Mata-Espinosa D, Marquina-Castillo B, Barrios-Payan J, et al. Granulocyte-macrophage colony-stimulating factor: Not just another haematopoietic growth factor. Med Oncol 2014;31:774.
Wang J, Tang ZY, Ka W, Sun D, Yao W, Wen Z, et al. Synergistic effect of cytokines EPO, IL-3 and SCF on the proliferation, differentiation and apoptosis of erythroid progenitor cells. Clin Hemorheol Microcirc 2007;37:291-9.
Koller MR, Bender JG, Miller WM, Papoutsakis ET. Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology 1993;11:358-63.
Kobari L, Giarratana MC, Poloni A, Firat H, Labopin M, Gorin NC, et al. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant 1998;21:759-67.
Vassiliou I, Lolis E, Nastos C, Tympa A, Theodosopoulos T, Dafnios N, et al. The combined effect of erythropoietin and granulocyte macrophage colony stimulating factor on liver regeneration after major hepatectomy in rats. World J Surg Oncol 2010;8:57.
Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, et al. Interleukin-11 stimulates the proliferation of human hematopoietic CD34 and CD34 CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp Hematol 1993;21:1668-72.
